This single-centre, partially blinded trial randomized 26 patients undergoing emergency surgery for acute type A aortic dissection to heparin-dose response or activated clotting time-guided anticoagulation. The primary endpoint, change in prothrombin fragment 1+2 from baseline to heparin reversal, did not differ significantly: median 333 versus -92 pmol/L, respectively (p=0.31). Both groups had baseline consumptive coagulopathy and ongoing intraoperative thrombin generation. Secondary endpoints, including bleeding, transfusion and clinical outcomes assessed through 90 days, were reported as comparable, except for a lower protamine-to-heparin ratio with heparin-dose response guidance.
This small trial found no statistically significant difference in the thrombin-generation endpoint between strategies. It does not establish equivalence in bleeding, transfusion or clinical outcomes.
Study limitation: Only 26 patients were randomized at one centre, and baseline F1+2 differences complicate interpretation of the surrogate primary endpoint.
AI-generated from the published abstract with automated source checks. For research discovery; consult the original paper before applying findings.